These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003. Mesa RA Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349 [TBL] [Abstract][Full Text] [Related]
5. Myelofibrosis with myeloid metaplasia. Guardiola P; Anderson JE; Gluckman E N Engl J Med; 2000 Aug; 343(9):659; author reply 659-60. PubMed ID: 10979803 [No Abstract] [Full Text] [Related]
6. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia. Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124 [TBL] [Abstract][Full Text] [Related]
7. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new. Tefferi A Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877 [TBL] [Abstract][Full Text] [Related]
8. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032 [TBL] [Abstract][Full Text] [Related]
9. [Subleukemic myelosis - myelofibrosis]. Demidova AV Ter Arkh; 1982; 54(9):135-43. PubMed ID: 7179142 [No Abstract] [Full Text] [Related]
10. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Mesa RA; Elliott MA; Tefferi A Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148 [TBL] [Abstract][Full Text] [Related]
11. [The onset of myelofibrosis with myeloid metaplasia]. Montero García JM; Juárez Alonso S; García Lescun MI; Soleto Sáez E; Patrón M; Gasalla Chacón R Rev Clin Esp; 1971 Jul; 122(6):19-24. PubMed ID: 5120071 [No Abstract] [Full Text] [Related]
12. [Prognostic value of bone and marrow lesions in primary myeloid splenomegaly]. Vorhauer-Atlan W; Jacquillat C; Briere J; Chelloul N Sem Hop; 1975 Apr; 51(18):1219-25. PubMed ID: 175472 [TBL] [Abstract][Full Text] [Related]
13. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation. Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970 [TBL] [Abstract][Full Text] [Related]